Description
CLINICAL PHARMACOLOGY
Drostanolone aches to androgen receptors; increasing nitrogen retention and protein synthesis. Drostanolone acts on DHT modulated pathways as well. Drostanolone is a potent estrogen antagonist and does not aromatize estrogen, limiting expression of side effects often linked to estrogen such as water retention, gynecomastia, and some types of high blood pressure. Drostanolone undergoes hepatic metabolism with a half- life of 2-3 days after separation of the ester.
INDICATIONS
To rapidly restore muscle tissue atrophied during recovery from a traumatic injury. To offset muscle catabolism in patients with a wasting syndrome. To treat certain types of anemia which are non-responsive to first line agents.
Estrogen antagonist in treatment of breast cancer.